A designed peptide nanomolar affinity inhibitor of protein aggregation in both Alzheimer's disease and type 2 diabetes

被引：0
|
作者：
Yan, L.-M. [1 ]
Velkova, A. [1 ]
Tatarek-Nossol, M. [1 ]
Andreetto, E. [1 ]
Kapurniotu, A. [1 ]
机构：
[1] Univ Hosp RWTH Aachen, Inst Biochem, Lab Bioorgan & Med I Chem, D-52074 Aachen, Germany
来源：
BIOPOLYMERS | 2007年 / 88卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：531 / 531
页数：1
相关论文
共 50 条
  • [31] Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes
    Nedjadi, Taoufik
    Haque, Absarul
    Alam, Qamre
    Gan, Siew H.
    Chaudhary, Adeel G.
    Abuzenadah, Adel M.
    Damanhouri, Ghazi A.
    Kamal, Mohammad A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 203 - 212
  • [32] Alzheimer's disease and Type 2 diabetes mellitus: the cholinesterase connection?
    Allam, Appa Rao
    Sridhar, Gumpeny Ramachandra
    Thota, Hanuman
    Babu, Changalasetty Suresh
    Prasad, Akula Siva
    Divakar, Ch
    LIPIDS IN HEALTH AND DISEASE, 2006, 5 (1)
  • [33] Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology
    Beeri, MS
    Silverman, JM
    Davis, KL
    Marin, D
    Grossman, HZ
    Schmeidler, J
    Purohit, DP
    Perl, DP
    Davidson, M
    Mohs, RC
    Haroutunian, V
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (04): : 471 - 475
  • [34] Molecular connections between Alzheimer's disease and type 2 diabetes
    Felice, F. D.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 25 - 25
  • [35] Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease
    Ganeshpurkar, Ankit
    Swetha, Rayala
    Kumar, Devendra
    Gangaram, Gore P.
    Singh, Ravi
    Gutti, Gopichand
    Jana, Srabanti
    Kumar, Dileep
    Kumar, Ashok
    Singh, Sushil K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (07) : 501 - 533
  • [36] The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease
    He, Ling
    Sun, Yi
    METABOLIC BRAIN DISEASE, 2021, 36 (07) : 1469 - 1479
  • [37] The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease
    Ling He
    Yi Sun
    Metabolic Brain Disease, 2021, 36 : 1469 - 1479
  • [38] The amyloid precursor protein of Alzheimer's disease and the Aβ peptide
    Storey, E
    Cappai, R
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1999, 25 (02) : 81 - 97
  • [39] Pentapeptide amides interfere with the aggregation of β-amyloid peptide of Alzheimer's disease
    Hetényi, C
    Szabó, Z
    Klement, T
    Datki, Z
    Körtvélyesi, T
    Zarándi, M
    Penke, B
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (04) : 931 - 936
  • [40] Soluble IAPP mimics as tailored IAPP receptor agonists and inhibitors of protein aggregation in type 2 diabetes (T2D) and Alzheimer's disease (AD)
    Kapurniotu, A.
    Yan, L-M.
    Velkova, A.
    Tatarek-Nossol, M.
    Andreetto, E.
    BIOPOLYMERS, 2011, 96 (04) : 477 - 477
12345